NovoCure Ltd Insider Trading for March 2021

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NovoCure Ltd.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NovoCure Ltd for March 2021.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 10 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS131.093,524461,961101,272104.8 K to 101.3 K (-3.36 %)
Mar 10 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS130.812,627343,627104,796107.4 K to 104.8 K (-2.45 %)
Mar 10 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS130.81765100,06735,89336.7 K to 35.9 K (-2.09 %)
Mar 10 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS130.812,404314,45867,71470.1 K to 67.7 K (-3.43 %)
Mar 10 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...SellS130.81765100,06790,04590.8 K to 90 K (-0.84 %)
Mar 10 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS130.813,004392,941153,684156.7 K to 153.7 K (-1.92 %)
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM7.1513,987100,0070
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS131.534,550598,462107,423112 K to 107.4 K (-4.06 %)
Mar 09 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM7.1513,987100,007111,97398 K to 112 K (+14.27 %)
Mar 09 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS131.532,918383,80533,25936.2 K to 33.3 K (-8.07 %)
Mar 08 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS137.553,854530,133156,688160.5 K to 156.7 K (-2.40 %)
Mar 08 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS137.553,084424,21770,11873.2 K to 70.1 K (-4.21 %)
Mar 08 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...SellS137.5556777,99390,81091.4 K to 90.8 K (-0.62 %)
Mar 08 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...GiftG0.00910036,65837.6 K to 36.7 K (-2.42 %)
Mar 08 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS137.5556777,99337,56838.1 K to 37.6 K (-1.49 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseM69.373,475241,06122,878
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS137.551,888259,70236,17738.1 K to 36.2 K (-4.96 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...SellS150.783,475523,96138,06541.5 K to 38.1 K (-8.37 %)
Mar 05 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...BuyM69.373,475241,06141,54038.1 K to 41.5 K (+9.13 %)
Mar 05 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS137.552,658365,61997,986100.6 K to 98 K (-2.64 %)
Mar 05 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS150.782,174327,796100,644102.8 K to 100.6 K (-2.11 %)
Mar 04 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...Option ExerciseA153.0916,0032,449,89916,003
Mar 04 2021NVCRNovoCure LtdWeinberg UriChief Science Offic ...GrantA0.008,709036,30627.6 K to 36.3 K (+31.56 %)
Mar 04 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...Option ExerciseA153.0916,0032,449,89916,003
Mar 04 2021NVCRNovoCure LtdBenaim ElyChief Medical Offic ...GrantA0.008,709038,06529.4 K to 38.1 K (+29.67 %)
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...Option ExerciseA153.0920,0043,062,41220,004
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...GrantA0.0010,886038,13527.2 K to 38.1 K (+39.95 %)
Mar 04 2021NVCRNovoCure LtdCordova AshleyChief Financial Off ...SellS152.0542865,07927,24927.7 K to 27.2 K (-1.55 %)
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...Option ExerciseA153.0923,0043,521,68223,004
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...GrantA0.0012,5190160,542148 K to 160.5 K (+8.46 %)
Mar 04 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...SellS152.052,392363,711148,023150.4 K to 148 K (-1.59 %)
Mar 04 2021NVCRNovoCure LtdScannell Timothy JDirectorOption ExerciseA153.097,9291,213,8517,929
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseA153.0920,0043,062,41220,004
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...GrantA0.0010,8860102,81891.9 K to 102.8 K (+11.84 %)
Mar 04 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...SellS152.05912138,67291,93292.8 K to 91.9 K (-0.98 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselOption ExerciseA153.0919,0042,909,32219,004
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselGrantA0.0010,342073,20262.9 K to 73.2 K (+16.45 %)
Mar 04 2021NVCRNovoCure LtdLongsworth Todd ChristopherGeneral CounselSellS152.052,355358,08562,86065.2 K to 62.9 K (-3.61 %)
Mar 02 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...Option ExerciseM0.003,08600
Mar 02 2021NVCRNovoCure LtdShah PriteshChief Commercial Of ...BuyM149.103,086460,12392,84489.8 K to 92.8 K (+3.44 %)
Mar 02 2021NVCRNovoCure LtdDanziger AsafChief Executive Off ...Option ExerciseM0.009,25900
Mar 02 2021NVCRNovoCure LtdDanziger AsafChief Executive Off ...BuyM149.109,2591,380,517206,944197.7 K to 206.9 K (+4.68 %)
Mar 02 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...Option ExerciseM0.001,46500
Mar 02 2021NVCRNovoCure LtdLeonard Frank XChief Development O ...BuyM149.101,465218,43283,09881.6 K to 83.1 K (+1.79 %)
Mar 02 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...Option ExerciseM0.007,71500
Mar 02 2021NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Off ...BuyM149.107,7151,150,307150,415142.7 K to 150.4 K (+5.41 %)

Contact us | Follow us on Twitter